PanGen Biotech (222110.KQ) Stock Price

PanGen Biotech Price

CLOSED
4,670.00
​
Market closed

Over the last 12 years PanGen Biotech grew revenue by 12.7% annually, reaching 13.42 B KRW. For PanGen Biotech, the net margin of 15.3% is up versus -41.7% a few years ago.

PanGen Biotech stock price

Access this data via the Eulerpool API

PanGen Biotech business model & stock analysis

PanGen Biotech, Inc. engages in the development of biopharmaceutical products. The company is headquartered in Suwon, Gyeonggi-Do and currently employs 73 full-time employees. The company went IPO on 2016-03-11. The firm mainly provides contract services for the manufacture of bio pharmaceuticals, bio pharmaceuticals development technology transfer services for the manufacture of Chinese hamster ovary (CHO) cell lines and the process of products and gains royalty from the services. The firm also provides reagents which are used for the development of bio pharmaceuticals. In addition the Company is also engaged in the development of bio pharmaceuticals such as Biosimilar EPO, Recombinant Factor VIII and Biosimilar G-CSF. The firm provides its services within domestic market and to overseas markets such as China, India, Mexico, America and Europe.

Frequently asked questions about PanGen Biotech

Converted at the current exchange rate, the PanGen Biotech share trades at 3.11 EUR (4,670.00 KRW).

The revenue cannot currently be calculated for PanGen Biotech.

The profit cannot currently be calculated for PanGen Biotech.

The P/E ratio cannot be calculated for PanGen Biotech at the moment.

The P/S cannot be calculated for PanGen Biotech currently.

The Eulerpool Quality Score for PanGen Biotech is 6/10.

The ISIN of PanGen Biotech is KR7222110009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PanGen Biotech is 222110.KQ. The ticker symbol is used to trade PanGen Biotech shares on the stock exchange.

Fair ValueTerminal
4,016.20 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
183.79 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website pangen.com
Country
South Korea
Currency
KRW
Initial public offering
Mar 11, 2016
ISIN
KR7222110009
Cusip
Y6S62Y100
Market capitalization
53.42 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
35.47
P/B Ratio
1.79
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.85 %
Last updated Oct 9, 2026, 3:58 AM

PanGen Biotech Peer Group

PanGen Biotech FIGI

222110:KS · BBG000MQ7D56222110:KQ · BBG00B9WQHZ1